A study of the analytical behaviour of selected new molecular entities using electrospray ionisation ion trap mass spectrometry, liquid chromatography, gas chromatography and polarography and their determination in serum at therapeutic concentrations
- 15 August 2008
- journal article
- Published by Elsevier BV in Analytica Chimica Acta
- Vol. 623 (2), 221-230
- https://doi.org/10.1016/j.aca.2008.06.025
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Determination of rosuvastatin in rat plasma by HPLC: validation and its application to pharmacokinetic studiesBiomedical Chromatography, 2006
- Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC–MS/MS with electrospray ionization: Assay development, validation and application to a clinical studyJournal of Pharmaceutical and Biomedical Analysis, 2005
- Analysis of five HMG‐CoA reductase inhibitors— atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studiesBiomedical Chromatography, 2005
- Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatographyBiomedical Chromatography, 2005
- Simple and Simultaneous Determination of the HIV-Protease Inhibitors Amprenavir, Atazanavir, Indinavir, Lopinavir, Nelfinavir, Ritonavir and Saquinavir Plus M8 Nelfinavir Metabolite and the Nonnucleoside Reverse Transcriptase Inhibitors Efavirenz and Nevirapine in Human Plasma by Reversed-Phase Liquid ChromatographyTherapeutic Drug Monitoring, 2005
- IntroductionNature Reviews Drug Discovery, 2004
- A Simple HPLC Method for Simultaneous Determination of Lopinavir, Ritonavir and EfavirenzCHEMICAL & PHARMACEUTICAL BULLETIN, 2003
- AtazanavirDrugs, 2003
- TipranavirDrugs, 2003
- Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor AntagonistNew England Journal of Medicine, 1999